InsidersTradesSigma
Track the TECTONIC THERAPEUTIC INC share price and the full management transaction log of the company, a listed equity based in United States. Shares are listed on the US market, under the oversight of SEC (Form 4). Market capitalisation: €585.3m. The latest transaction was reported on 12 August 2026 (Notice of proposed sale (Form 144)). Among the most active insiders: PETER MCNAMARA. All data is accessible without an account.
Analysts rate TECTONIC THERAPEUTIC INC Strong Buy (bullish), based on 9 analysts. Average price target: US$77.56.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
1 of 1 declaration
TECTONIC THERAPEUTIC INC is a company focused on developing innovative therapies for the treatment of neurological diseases. It is listed on the NASDAQ under the ticker TECT.